KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) EBT (2016 - 2025)

Historic EBT for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $3.9 billion.

  • Amgen's EBT rose 2644.31% to $3.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 billion, marking a year-over-year increase of 7619.15%. This contributed to the annual value of $4.6 billion for FY2024, which is 4132.4% down from last year.
  • Amgen's EBT amounted to $3.9 billion in Q3 2025, which was up 2644.31% from $1.6 billion recorded in Q2 2025.
  • Amgen's 5-year EBT high stood at $3.9 billion for Q3 2025, and its period low was -$68.0 million during Q1 2024.
  • Its 5-year average for EBT is $1.8 billion, with a median of $1.7 billion in 2022.
  • Per our database at Business Quant, Amgen's EBT tumbled by 10197.56% in 2024 and then soared by 300147.06% in 2025.
  • Over the past 5 years, Amgen's EBT (Quarter) stood at $2.1 billion in 2021, then decreased by 17.97% to $1.7 billion in 2022, then plummeted by 51.26% to $852.0 million in 2023, then fell by 8.22% to $782.0 million in 2024, then soared by 401.41% to $3.9 billion in 2025.
  • Its EBT stands at $3.9 billion for Q3 2025, versus $1.6 billion for Q2 2025 and $2.0 billion for Q1 2025.